Skip to content

LIFECODES HLA-B eRES SSO Typing Kit for use with Luminex 628917Recalls & reported problems

Immucor Gti Diagnostics, Inc. · DNA Typing of Class I HLA alleles, to aid in transfusion and transplantation donor and recipient matching · Class U

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10888234400035), received between Aug 30, 2018 and Aug 30, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Off-Label Use” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Off-Label Use1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 30, 2018Off-Label Use; Off-Label Use

    CUSTOMER HAS REPORTED ((B)(4)) TO THE TECHNICAL SALE SPECIALIST ON AUGUST 2, 2018, DURING A ROUTINE VISIT THAT THE HLA-B ALLELE ASSIGNMENTS FOR SAMPLE (B)(6) OBTAINED USING LIFECODES HLA-B ERES SSO TYPING KIT (LOT 01117B), DID NOT AGREE WITH THE PATIENT FIRST DNA SAMPLE ASSIGNMENT WHICH WAS OBTAINED USING AN ALTERNATE VENDOR'S KIT BACK IN 2015. THE ALLELES ASSIGNED FOR SAMPLE (B)(6) ON (B)(6) 2018 WERE HLA-B*57:04 HOMOZYGOUS COMPARED TO HLA-B*57:04, B*15:01 FOR THE FIRST SAMPLE BY THE ALTERNATE VENDOR'S KIT BACK IN 2015. THE CUSTOMER INDICATED AS PART OF THEIR INTERNAL INVESTIGATION, THEY REPEATED THE SAMPLE USING THE ABOVE MENTIONED LOT NUMBER AND GOT SIMILAR RESULTS I.E. HLA-B*57:04 HOMOZYGOUS FOR SAMPLE (B)(6) AND HLA-B*57:04, B*15:01 HETEROZYGOUS FOR THE SAMPLE. AS PART OF THE SAME INTERNAL INVESTIGATION SAMPLE (B)(6)7 WAS TESTED USING PCR-SSP WHICH GAVE HLA-B*57:04, B*15:01 HETEROZYGOUS ASSIGNMENT SIMILAR TO THE ALTERNATE VENDOR'S ASSIGNMENT BACK IN 2015. IMMUCOR TECHNICAL SUPPORT IDENTIFIED THAT THE CUSTOMER WAS USING THE PRODUCT OFF LABEL WHERE SET UP OF THE ASSAY WAS USING A 1/2 VOLUME PROTOCOL. THE CUSTOMER WAS ADVISED TO RETEST THE SAMPLE USING THE STANDARD PROTOCOL INDIC

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7833214 ↗

Other Test,Qualitative,For Hla,Non-Diagnostic devices

All Test,Qualitative,For Hla,Non-Diagnostic devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page